BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 2, 2025
See today's BioWorld
Home
» Other news to note for April 2, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for April 2, 2020
April 2, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Adaptive, Advanz, Aicuris, Alnylam, Amgen, Ansun, Apeptico, Astrazeneca, Aurobindo, Axxam, Bharat, Bioaegis, Celator, Celularity, Cobra, Combigene, Cortexyme, Cytodyn, Elevation, Ennaid, ERS, Evotec, Flugen, Foamix, 14ner, Ipsen, Kite, La Jolla, Leo, Menlo, Merck, Merrimack, Novartis, Noxopharm, Paratek, Perrigo, Persephone, Ra, Redhill, Relief, Sandoz, Serimmune, Sonnet, Sorrento, Tetra, Teva, UCB, Vir, Zealand.
BioWorld
Briefs
Other news to note
Coronavirus